AU Patent

AU681924B2 — 3-acylaminobenzazepines

Assigned to Merck and Co Inc · Expires 1997-09-11 · 29y expired

What this patent protects

PCT No. PCT/US94/13413 Sec. 371 Date May 16, 1996 Sec. 102(e) Date May 16, 1996 PCT Filed Nov. 21, 1994 PCT Pub. No. WO95/14671 PCT Pub. Date Jun. 1, 1995This invention is concerned with novel compounds represented by structural formula I and II. <IMAGE> I <IMAGE&gt…

USPTO Abstract

PCT No. PCT/US94/13413 Sec. 371 Date May 16, 1996 Sec. 102(e) Date May 16, 1996 PCT Filed Nov. 21, 1994 PCT Pub. No. WO95/14671 PCT Pub. Date Jun. 1, 1995This invention is concerned with novel compounds represented by structural formula I and II. <IMAGE> I <IMAGE> II which are antiarrhythmic agents.

Drugs covered by this patent

Patent Metadata

Patent number
AU681924B2
Jurisdiction
AU
Classification
—
Expires
1997-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.